Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy
Charalampos Charalampous(The Ohio State University Wexner Medical Center), Shaji Kumar(Mayo Clinic in Arizona), Francis K. Buadi, Morie A. Gertz(Mayo Clinic in Arizona), Yi Lin(Mayo Clinic), Nelson Leung(Memorial Sloan Kettering Cancer Center), Robert A. Kyle(Mayo Clinic in Arizona), Prashant Kapoor, Amie Fonder, Moritz Binder(Mayo Clinic in Arizona), Utkarsh Goel, Yi L. Hwa, Rahma Warsame, Joselle Cook(Mayo Clinic), S. Vincent Rajkumar(Mayo Clinic), Wilson I. Gonsalves(Mayo Clinic), Taxiarchis Kourelis, Martha Q. Lacy, Suzanne R. Hayman, Angela Dispenzieri(WinnMed), Miriam Hobbs, David Dingli
Cited by 16
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k